Intrathecal Rituximab in Progressive Multiple Sclerosis

NCT02545959 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
10
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Centre Hospitalier de PAU

Collaborators